Research theme for competitive and other funds (18)：
2021 - 2024 Impact of systemic iron overload on the bone marrow hematopoiesis and malignant progression.
2018 - 2021 Biological function of CD109 in hematopoiesis.
2017 - 2019 Development of hematopoietic stem cell products by using multiple cord blood units
2015 - 2019 Bone marrow microenvironment and drug resistance in myelodysplastic syndromes
2010 - 2012 Analysis of the tumor regulatory molecule, c-Cbl.
2008 - 2009 Analysis of regulatory mechanism of hematopoiesis and exploration of the pathogenesis of hematopoietic neoplasms through comprehensive genetic analysis
2006 - 2007 GENMOME-WIDEANALYSIS OF GENETIC BASIS OF HEMATOLOGICAL MALIGNANCIES
2004 - 2005 Exploring leukemogenic mechanism using genomic analysis and mouse genetics.
2002 - 2004 Assessment of immune modulation by Notch signaling-exploration of immunomodulatory intervention targeting Notch system.
2002 - 2003 GENOM IC ANALYSIS OF (1;7) TRANSLOCATION AND del(7q) IN MYELODYSPLASTIC SYNDROME
鉄過剰症の造血に与える影響に関する研究
MDS発症原因分子の解析
Analysis of MDS-related genes
Show all
Papers (65)：
Tomoya Maeda, Akira Matsuda, Junya Kanda, Hiroshi Kawabata, Takayuki Ishikawa, Kaoru Tohyama, Akira Kitanaka, Kayano Araseki, Kei Shimbo, Tomoko Hata, et al. Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry. British journal of haematology. 2024
Yasushi Miyazaki, Toru Kiguchi, Shinya Sato, Kensuke Usuki, Ken Ishiyama, Yoshikazu Ito, Takahiro Suzuki, Jun Taguchi, Shigeru Chiba, Nobuaki Dobashi, et al. Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial. International journal of hematology. 2022. 116. 2. 228-238
Hiroshi Kawabata, Kensuke Usuki, Maki Shindo-Ueda, Junya Kanda, Kaoru Tohyama, Akira Matsuda, Kayano Araseki, Tomoko Hata, Takahiro Suzuki, Hidekazu Kayano, et al. Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes. International journal of hematology. 2019. 110. 5. 533-542
Akira Matsuda, Hiroshi Kawabata, Kaoru Tohyama, Tomoya Maeda, Kayano Araseki, Tomoko Hata, Takahiro Suzuki, Hidekazu Kayano, Kei Shimbo, Kensuke Usuki, et al. Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review study. Leukemia research. 2018. 74. 137-143
Toru Kiguchi, Shinya Sato, Kensuke Usuki, Ken Ishiyama, Yoshikazu Ito, Takahiro Suzuki, Jun Taguchi, Shigeru Chiba, Nobuaki Dobashi, Akihiro Tomita, et al. Prospective Comparison of Azacitidine Treatment between 7-Days and 5-Days Schedules for Patients with Higher-Risk Myelodysplastic Syndromes; Results of Japan Adult Leukemia Study Group MDS212 Trial. BLOOD. 2019. 134
Prognostic factors for patients with myelodysplastic syndromes. 2017. 74. 5. 637-643
Yasufumi Kawasaki, Kazuya Sato, Norihito Takayama, Hiroko Hayakawa, Kiyomi Mashima, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kento Umino, Daisuke Minakata, et al. Comprehensive Analysis of Activation and Proliferation Kinetics and Effector Functions of Human Lymphocyte Subsets in Xenogeneic GvHD Model. BLOOD. 2016. 128. 22
Yasuhisa Yokoyama, Masahiko Gosho, Takahiro Suzuki, Akiyoshi Takami, Yasushi Miyazaki, Koichi Akashi, Shigeru Chiba. Analysis of the Prevalence and Risk Factors of Adult Neutropenia in a Large Cohort in Japan. BLOOD. 2016. 128. 22
Management of patients with myelodysplastic syndromes after azacitidine treatment failure. 2016. 72. 5. 557-561
- 2000 Graduate School, The University of Tokyo Division of Medical Science
- 1993 The University of Tokyo Faculty of Medicine School of Medicine
Professional career (1)：
医学博士 (東京大学)
Work history (3)：
2016/10 - 現在 Kitasato University School of Medicine Department of Hematology Professor
2015/07 - 2016/09 自治医科大学医学部 内科学講座血液学部門 准教授
2007/04 - 2015/06 Jichi Medical University Division of Hematology, Department of Medicine Assistant Professor
Association Membership(s) (6)：
The Japan Society for hematopoietic stem cell transplantation
, THE JAPANESE CANCER ASSOCIATION
, THE JAPANESE SOCIETY OF HEMATOLOGY
, AMERICAN SOCIETY OF HEMATOLOGY
, JAPAN SOCIETY OF CLINICAL ONCOLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
